Click here to view Phynova's corporate presentation (482kb)
Power of
Plants
Mankind has for centuries
relied on plants as a valuable source of therapeutic agents to treat disease and maintain good health. Using traditional Chinese medicines (TCM) as a discovery engine and starting point, Phynova develops patent-protected pharmaceuticals, OTC drugs, cosmetic and functional ingredients.
Drug Candidates
Melokinex™ POI
For Post Operative Ileus
Phytobacx™ MRSA
For MRSA and Acne
PYN17 Hepatitis C
For Chronic Hepatitis C
PYN22 Metabolic disorders
For Obesity/Non Alcoholic Fatty Liver Disease ('NAFLD')
PYN8 Metabolic disorders
For Type-2 Diabetes
Consumer Healthcare
THMPs
Multiple indications to be registered under THMP Directive
Relivergen™
Supplement for general liver health
IminoNorm™
Supplement for blood-glucose control
FatigFix™
Supplement for fatigue and troubled sleep
Pipeline
Phynova has identified a number of Drug Candidates in the fields of anti-virals, anti-microbials, gasteroenterology, and anti-inflammatories, as well as developing products for the OTC and Consumer and Personal Healthcare markets.
News
Preliminary Melokinex™ Phase 2 Clinical Trial Results
Feb 2012 - Phynova is pleased to announce the successful completion of a Phase 2 clinical study for its lead drug candidate, Melokinex™... More